1.
An Med Interna
; 10(10): 484-6, 1993 Oct.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-8136425
RESUMO
We performed a study of antigens HLA type I and II (specificity DR) in 90 patients with diagnosis of Rheumatoid Arthritis (RA) treated with Sodium Aurothiomalate (SATM) in order to detect the presence of an antigen HLA which could act as a protective factor against toxicity by SATM. Our results demonstrated a decrease in the frequency of the antigen DR7 in patients with toxicity by SATM, which suggests a protective factor of this antigen against the development of toxic reactions due to gold salts.
Assuntos
Artrite Reumatoide/tratamento farmacológico , Tiomalato Sódico de Ouro/efeitos adversos , Antígeno HLA-DR7/imunologia , Adulto , Artrite Reumatoide/imunologia , Feminino , Tiomalato Sódico de Ouro/imunologia , Tiomalato Sódico de Ouro/uso terapêutico , Antígeno HLA-DR7/análise , Humanos , Masculino , Pessoa de Meia-Idade
2.
Ginecol Obstet Mex
; 39(232): 121-7, 1976 Feb.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-770242